Indegene Share Price
605.15+5.00 (+0.83%)
+9.43% past 1 Year
News
Indegene gets preliminary US court nod for class action settlement
Equity
INDGN
Indegene Ltd sees Rs 39.34 crores NSE block trade at Rs 565
Equity
INDGN
Indegene schedules investor and analyst meetings on August 24-25, 2026
Equity
INDGN
Indegene subsidiary settles lawsuit with potential payout of USD 47.20 lakhs
Equity
INDGN
Indegene sees Rs 1105.26 crore NSE block trade at Rs 525 per share
Equity
INDGN
Indegene Q1 EBITDA grows year-on-year but margin compresses sharply
Equity
INDGN
Indegene Q1 revenue rises sharply year-on-year in reported results
Equity
INDGN
Indegene Q1 net profit flat at Rs 116 crores on year-on-year basis
Equity
INDGN
Indegene schedules Q1 FY26 earnings conference call on July 31 at 9 am
Equity
INDGN
Indegene informs about analyst meet
Equity
INDGN
Indegene: Recognized As A Top Performer In Isg Provider Lens™ For Life Sciences Digital Services 2026.
Equity
INDGN
Indegene gains even after reporting 32% fall in Q4 consolidated net profit
Equity
INDGN
Indegene reports 32% fall in Q4 consolidated net profit
Equity
INDGN
Indegene EBITDA Margins to Recover to Higher Levels in H2 FY2027 on Robust Pipeline, Biopharm Integration.
Equity
INDGN
Indegene Recommends Final Dividend of Rs 2.25 Per Share in Corporate Results.
Equity
INDGN
Indegene Q4FY25 Results: Net Profit Declines 34% YoY to Rs 79.70 Crores, Revenue Grows 33% to Rs 1000 Crores.
Equity
INDGN
Indegene reports Profit after tax of 72.10 Crores, in the March 2026 quarter
Equity
INDGN
Indegene informs about conference call
Equity
INDGN
Indegene informs about analyst meet
Equity
INDGN
Indegene informs about allotment of shares
Equity
INDGN